These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7035306)

  • 21. Altered aortic and cremaster muscle prostaglandin synthesis in diabetic rats.
    Myers TO; Messina EJ; Rodrigues AM; Gerritsen ME
    Am J Physiol; 1985 Oct; 249(4 Pt 1):E374-9. PubMed ID: 2931995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dietary cholesterol on the release of prostacyclin from the mesenteric vascular bed in diabetic rat.
    Fujii K; Horrobin DF; Huang YS
    Diabete Metab; 1987 Apr; 13(2):87-91. PubMed ID: 3297837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet adhesion and aggregation in arteries of rats, rabbits and guinea pigs in vivo and in vitro correlate negatively with their prostacyclin (PG I2) production.
    Tschopp TB; Baumgartner HR
    Agents Actions Suppl; 1979; (4):156-62. PubMed ID: 386741
    [No Abstract]   [Full Text] [Related]  

  • 24. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced prostacyclin activity in systemic lupus erythematosus.
    McVerry BA; Machin SJ; Parry H; Goldstone AH
    Ann Rheum Dis; 1980 Oct; 39(5):524-5. PubMed ID: 7002067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ditazol on the vascular retinal pattern in experimental diabetes in rats.
    Moreno A; De La Cruz JP; Mérida F; García Campos J; Sánchez de la Cuesta F
    Haemostasis; 1995; 25(4):166-71. PubMed ID: 7557655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis.
    Leithner C; Sinzinger H; Silberbauer K; Stummvoll HK
    Proc Eur Dial Transplant Assoc; 1981; 18():122-5. PubMed ID: 7036146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased plasminogen activator but normal prostacyclin activity in rat veins during development of experimental thrombosis.
    Mysliwiec M; Villa S; Kornblihtt L; de Gaetano G; Donati MB
    Thromb Res; 1980 Apr 1-15; 18(1-2):159-65. PubMed ID: 6996209
    [No Abstract]   [Full Text] [Related]  

  • 29. Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.
    Ceylan A; Karasu C; Aktan F; Ozansoy G
    Diabetes Nutr Metab; 2004 Aug; 17(4):203-10. PubMed ID: 15575340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase.
    Wong PY; Chao PH; McGiff JC
    J Pharmacol Exp Ther; 1982 Dec; 223(3):757-60. PubMed ID: 6754908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. II. Correlation between lipid peroxides, thromboxane A2/prostacyclin, and platelet aggregation in different stages of diabetes.
    Somova L; Kamenov V; Doncheva M; Kirilov G; Vassileva M
    Acta Physiol Pharmacol Bulg; 1988; 14(3):57-62. PubMed ID: 3066112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nafazatrom in treatment of thrombotic thrombocytopenic purpura.
    Durrant ST; Joosten P; Gordon-Smith EC
    Lancet; 1985 Oct; 2(8459):842. PubMed ID: 2864567
    [No Abstract]   [Full Text] [Related]  

  • 33. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
    Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of rimonabant, the cannabinoid CB1 receptor antagonist, on peripheral nerve in streptozotocin-induced diabetic rat.
    Liu WJ; Jin HY; Park JH; Baek HS; Park TS
    Eur J Pharmacol; 2010 Jul; 637(1-3):70-6. PubMed ID: 20406631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cod liver oil on tissue antioxidant pathways in normal and streptozotocin-diabetic rats.
    Hünkar T; Aktan F; Ceylan A; Karasu C;
    Cell Biochem Funct; 2002 Dec; 20(4):297-302. PubMed ID: 12415563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
    Chlopicki S; Swies J; Mogielnicki A; Buczko W; Bartus M; Lomnicka M; Adamus J; Gebicki J
    Br J Pharmacol; 2007 Sep; 152(2):230-9. PubMed ID: 17641676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats.
    Gerrard JM; Stuart MJ; Rao GH; Steffes MW; Mauer SM; Brown DM; White JG
    J Lab Clin Med; 1980 Jun; 95(6):950-8. PubMed ID: 6445927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni.
    Su W; Dai DZ; Liu HR; Na T; Dai Y
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1228-33. PubMed ID: 17973859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.
    De la Cruz JP; Moreno A; Muñoz M; García Campos JM; Sánchez de la Cuesta F
    J Pharmacol Exp Ther; 1997 Jan; 280(1):454-9. PubMed ID: 8996228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.